EYE DISORDERS CONGENITAL
Clinical trials for EYE DISORDERS CONGENITAL explained in plain language.
Never miss a new study
Get alerted when new EYE DISORDERS CONGENITAL trials appear
Sign up with your email to follow new studies for EYE DISORDERS CONGENITAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye injection trial aims to slow vision loss in inherited blindness
Disease control Recruiting nowThis study is testing an experimental drug called ultevursen, given as an injection into the eye, for people with a specific genetic type of retinitis pigmentosa (RP). The goal is to see if it can slow down the loss of vision over two years. About 81 participants will be randomly…
Matched conditions: EYE DISORDERS CONGENITAL
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Breakthrough eye injection trial offers hope for children born blind
Disease control Recruiting nowThis study is testing whether regular eye injections of an experimental drug called sepofarsen can improve vision in people with a specific genetic form of Leber congenital amaurosis (LCA), which causes severe vision loss from childhood. In this carefully designed trial, each par…
Matched conditions: EYE DISORDERS CONGENITAL
Phase: PHASE3 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC